UNSPSC 51151542: Hexafluronium bromide

This classification denotes an antispasmotic agent with the molecular formula C36H42N2.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B64NJG83K2, chemically known as 1,6-hexanediaminium, n, n-di-9h-fluoren-9-yl-n,n,n,n-tetramethyl-, dibromide but more generally known as hexafluorenium bromide, which bears US NIH Compound Identifier 3601. European Medicines Agency schedules Hexafluronium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14099MIG.

UNSPSC 51151542 Hexafluronium bromide, a Commodity code, shows no recent state and local procurement activity aligned with its nominal scope. The two most recent opportunities tagged to this code — Seminole County's IFB for naloxone and drug deactivation systems (due Jul 26, 2023) and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (due Apr 3, 2026) — involve pharmaceutical procurement and pharmacy benefit management, not hexafluronium bromide specifically. Neither solicitation references hexafluronium bromide as a line item or as part of the scope. The mismatch suggests that the code may have been applied incorrectly to these opportunities in source systems, or that state and local governments are not actively procuring hexafluronium bromide under this classification.

Without recent opportunities that actually solicit hexafluronium bromide, no reliable characterization of issuing-body mix, geographic concentration, or typical contract structure can be drawn from the source. The code presents low current procurement relevance for vendors in this commodity class.